(S)-(+)-allantoin
AlkaPlorer ID: AK000443
Synonym: '', '(2,5-Dioxo-4-imidazolidinyl)urea', 'MLS002473300', 'SO_UY_026.1', 'Allantoin', 'SMR000528073', '(S)-allantoin', 'MLS000737882', 'N-(2,5-Dioxo-4-imidazolidinyl)urea', '2,5-Dioxo-4-imidazolidinyl-urea', '5-Ureido-2,4-imidazolidindione', 'MLSMR', 'Cordianine', '5-Ureidohydantoin', '(R)-allantoin', '(R)-(-)-allantoin', 'Alantan\nSebical\nAllantol\nALLANTOIN\nCordianine\nGlyoxyldiureid\nGlyoxyldiureide\n5-Ureidohydantoin\nAVC/Dienestrolcream\nHydantoin, 5-ureido-', '4-ureido-2,5-imidazolidinedione', '(R)-Allantoin', 'allantoin', 'ConMedNP.2281', '(R)(-)-Allantoin', '(S)-Allantoin', 'Glyoxyldiureide', '(S)(+)-Allantoin'
IUPAC Name: [(4S)-2,5-dioxoimidazolidin-4-yl]urea
Structure
SMILES: NC(=O)N[C@H]1NC(=O)NC1=O
InChI: InChI=1S/C4H6N4O3/c5-3(10)6-1-2(9)8-4(11)7-1/h1H,(H3,5,6,10)(H2,7,8,9,11)/t1-/m0/s1
InChIKey: POJWUDADGALRAB-SFOWXEAESA-N
Reference
PubChem CID: 439714
CAS: 3844-67-5
LOTUS: LTS0174328
SuperNatural Ⅲ: SN0290897-02
NPASS: NPC141953
Source
Properties Information
Molecule Weight: 158.117
TPSA?: 113.32
MolLogP?: -2.1798
Number of H-Donors: 4
Number of H-Acceptors: 3
RingCount: 1
Activities Information
| Organism | Target Name | Standard Type | Standard Value | Standard Units | doi |
|---|---|---|---|---|---|
| Homo sapiens | Cytochrome P450 1A2 | AC50 | nan | None | None |
| Homo sapiens | Cytochrome P450 2C19 | AC50 | nan | None | None |
| Homo sapiens | Cytochrome P450 2C9 | AC50 | nan | None | None |
| Homo sapiens | Cytochrome P450 2D6 | AC50 | nan | None | None |
| Homo sapiens | Cytochrome P450 3A4 | AC50 | nan | None | None |
| Homo sapiens | Runt-related transcription factor 1/Core-binding factor subunit beta | Potency | 11220.2 | nM | None |
| Homo sapiens | Thyroid stimulating hormone receptor | Potency | 12589.3 | nM | None |
| Homo sapiens | Ubiquitin carboxyl-terminal hydrolase 1 | Potency | 25118.9 | nM | None |
| Severe acute respiratory syndrome coronavirus 2 | Replicase polyprotein 1ab | Inhibition | 17.32 | % | 10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | Inhibition | 0.21 | % | 10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | Inhibition | 9.66 | % | 10.21203/rs.3.rs-23951/v1 |
